Coassembly and Complementation of Gag Proteins from HIV-1 and HIV-2, Two Distinct Human Pathogens

Molecular Cell

Volumn 23, Issue 2, 2006, Pages 281-287

  Boyko, Vitaly ^a   Leavitt, Maria ^a   Gorelick, Robert ^a   Fu, William ^a   Nikolaitchik, Olga ^a   Pathak, Vinay K ^a   Nagashima, Kunio ^a   Hu, Wei Shau ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

HUMDISEASE; MICROBIO; MOLIMMUNO

Indexed keywords

GAG PROTEIN; LENTIVIRUS VECTOR; POLYPROTEIN; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; FLUORESCENCE ANALYSIS; HETEROLOGOUS EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MUTAGENESIS; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; VIRUS INTERFERENCE; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TITRATION; VIRUS VIRULENCE;

GENE PRODUCTS, GAG; GENETIC COMPLEMENTATION TEST; HIV-1; HIV-2; HUMANS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; PRIMATES;

EID: 33746127612     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2006.05.028     Document Type: Article

References (26)

1. Ako-Adjei D., Johnson M.C., and Vogt V.M. The retroviral capsid domain dictates virion size, morphology, and coassembly of gag into virus-like particles. J. Virol. 79 (2005) 13463-13472
2. Arien K.K., Abraha A., Quinones-Mateu M.E., Kestens L., Vanham G., and Arts E.J. The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. J. Virol. 79 (2005) 8979-8990
3. Bailes E., Gao F., Bibollet-Ruche F., Courgnaud V., Peeters M., Marx P.A., Hahn B.H., and Sharp P.M. Hybrid origin of SIV in chimpanzees. Science 300 (2003) 1713
4. Bennett R.P., and Wills J.W. Conditions for copackaging rous sarcoma virus and murine leukemia virus Gag proteins during retroviral budding. J. Virol. 73 (1999) 2045-2051
5. Blattner W., Gallo R.C., and Temin H.M. HIV causes AIDS. Science 241 (1988) 515-516
6. Browning C.M., Cagnon L., Good P.D., Rossi J., Engelke D.R., and Markovitz D.M. Potent inhibition of human immunodeficiency virus type 1 (HIV-1) gene expression and virus production by an HIV-2 tat activation-response RNA decoy. J. Virol. 73 (1999) 5191-5195
7. Buckman J.S., Bosche W.J., and Gorelick R.J. Human immunodeficiency virus type 1 nucleocapsid zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA. J. Virol. 77 (2003) 1469-1480
8. Chin M.P., Rhodes T.D., Chen J., Fu W., and Hu W.S. Identification of a major restriction in HIV-1 intersubtype recombination. Proc. Natl. Acad. Sci. USA 102 (2005) 9002-9007
9. Clavel F. HIV-2, the West African AIDS virus. AIDS 1 (1987) 135-140
10. Curlin M.E., Gottlieb G.S., Hawes S.E., Sow P.S., Ndoye I., Critchlow C.W., Kiviat N.B., and Mullins J.I. No evidence for recombination between HIV type 1 and HIV type 2 within the envelope region in dually seropositive individuals from Senegal. AIDS Res. Hum. Retroviruses 20 (2004) 958-963
11. Freed E.O., Englund G., and Martin M.A. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J. Virol. 69 (1995) 3949-3954
12. Gao F., Bailes E., Robertson D.L., Chen Y., Rodenburg C.M., Michael S.F., Cummins L.B., Arthur L.O., Peeters M., Shaw G.M., et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397 (1999) 436-441
13. Gorelick R.J., Henderson L.E., Hanser J.P., and Rein A. Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence. Proc. Natl. Acad. Sci. USA 85 (1988) 8420-8424
14. Gorelick R.J., Gagliardi T.D., Bosche W.J., Wiltrout T.A., Coren L.V., Chabot D.J., Lifson J.D., Henderson L.E., and Arthur L.O. Strict conservation of the retroviral nucleocapsid protein zinc finger is strongly influenced by its role in viral infection processes: characterization of HIV-1 particles containing mutant nucleocapsid zinc-coordinating sequences. Virology 256 (1999) 92-104
15. Gottlieb G.S., Sow P.S., Hawes S.E., Ndoye I., Coll-Seck A.M., Curlin M.E., Critchlow C.W., Kiviat N.B., and Mullins J.I. Molecular epidemiology of dual HIV-1/HIV-2 seropositive adults from Senegal, West Africa. AIDS Res. Hum. Retroviruses 19 (2003) 575-584
16. Hu C.D., and Kerppola T.K. Simultaneous visualization of multiple protein interactions in living cells using multicolor fluorescence complementation analysis. Nat. Biotechnol. 21 (2003) 539-545
17. Hu W.S., and Temin H.M. Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc. Natl. Acad. Sci. USA 87 (1990) 1556-1560
18. Huang M., Orenstein J.M., Martin M.A., and Freed E.O. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 69 (1995) 6810-6818
19. Kannangai R., Shaji R.V., Ramalingam S., Jesudason M.V., Abraham O.C., George R., Shanmugam A.P., Schwartz D.H., and Sridharan G. HIV-2 subtype circulating in India (south). J. Acquir. Immune Defic. Syndr. 33 (2003) 219-222
20. Kaye J.F., and Lever A.M. Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation. J. Virol. 72 (1998) 5877-5885
21. Nagai T., Ibata K., Park E.S., Kubota M., Mikoshiba K., and Miyawaki A. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat. Biotechnol. 20 (2002) 87-90
22. Reid P., MacInnes H., Cong M.E., Heneine W., and Garcia-Lerma J.G. Natural resistance of human immunodeficiency virus type 2 to zidovudine. Virology 336 (2005) 251-264
23. Ren J., Bird L.E., Chamberlain P.P., Stewart-Jones G.B., Stuart D.I., and Stammers D.K. Structure of HIV-2 reverse transcriptase at 2.35 Å resolution and the mechanism of resistance to non-nucleoside inhibitors. Proc. Natl. Acad. Sci. USA 99 (2002) 14410-14415
24. Ryan-Graham M.A., and Peden K.W. Both virus and host components are important for the manifestation of a Nef- phenotype in HIV-1 and HIV-2. Virology 213 (1995) 158-168
25. Unutmaz D., Kewalramani V.N., Marmon S., and Littman D.R. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J. Exp. Med. 189 (1999) 1735-1746
26. Weiss R.A. HIV and AIDS in relation to other pandemics. EMBO Rep. 4 Spec No (2003) S10-S14